Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01924364 · ClinicalTrials.gov registry record · NA
Effect of Concentrating Endogenous Stromal Cells in the Fat Graft Using TGI Device
A NA study, sponsored by J. Peter Rubin, MD.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT01924364: Completed NA study, sponsored by J. Peter Rubin, MD.
NCT01924364 is a NA study that has completed, run by J. Peter Rubin, MD. The registered enrollment target is 7 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01924364, a NA study, has completed, sponsored by J. Peter Rubin, MD.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
The overall purpose of this research is to evaluate the physical changes that occur over time after fat grafting for craniofacial trauma. This protocol is similar to an existing study (IRB# PRO0906101) presently conducted at the University of Pittsburgh by the same research team which utilizes fat grafts. The preparation of the fat graft material in each clinical trial is processed differently evaluating the effects of graft resorption after treatment.
Primary Outcome
Facial appearance and persistence of treatment effect will be assessed using high resolution CT scanning with 3D reconstruction. Patients will be followed for 24 months after treatment to define long term outcomes.
Interventions
- DEVICE Tissue Genesis Cell Isolation System™ (TGI CIS)
- PROCEDURE Standard of care fat grafting
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2012-06-30 |
| Est. Completion | 2016-09-28 |
| Phase | NA |
What the finished NCT01924364 record still lists
NCT01924364 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Tissue Genesis Cell Isolation System™ (TGI CIS) is the first listed.
NCT01924364 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01924364 about?
NCT01924364 is a clinical study titled "Effect of Concentrating Endogenous Stromal Cells in the Fat Graft Using TGI Device". The overall purpose of this research is to evaluate the physical changes that occur over time after fat grafting for craniofacial trauma. This protocol is similar to an existing study (IRB# PRO0906101) presently conducted at the University of Pittsburgh by the same research team which utilizes fat g...
What is the current status of trial NCT01924364?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2012-06-30. Estimated completion is 2016-09-28.
What interventions are being tested in trial NCT01924364?
The interventions under investigation include: Tissue Genesis Cell Isolation System™ (TGI CIS) (DEVICE), Standard of care fat grafting (PROCEDURE).
Who is sponsoring clinical trial NCT01924364?
This trial is sponsored by J. Peter Rubin, MD, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01924364's enrollment target sits among peer trials
7 1982nd of 2000 higher than 18 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI